EHC

SEC source: 0001127602-21-022092 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,883

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $79.89. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-020439 · form4.xml · nonDerivative · entry 1

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,269

F1 · kind: Restricted shares forfeited upon resignation in accordance with the terms of the 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015994 · form4.xml · nonDerivative · entry 1

Williams Terrance · CIK 0001798480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,865

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015993 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,925

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015992 · form4.xml · nonDerivative · entry 1

SCHLICHTING NANCY M · CIK 0001376358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,958

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015991 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,016

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015989 · form4.xml · nonDerivative · entry 1

Maryland Patricia Anne · CIK 0001798468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,865

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015987 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,149

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015986 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,176

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015985 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,149

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015983 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,243

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015984 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,766

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015982 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,006

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015981 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,278

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015980 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,865

F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-015817 · form4.xml · derivative · entry 7

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,478

Underlying: Encompass Health Common Stock · 3,240 shares

Expires 2030-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.expiration_date: In connection with the reporting person's previously announced departure on June 18, 2021, the options will expire on September 16, 2021.

SEC source: 0001127602-21-015817 · form4.xml · derivative · entry 6

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,172

Underlying: Encompass Health Common Stock · 4,343 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.expiration_date: In connection with the reporting person's previously announced departure on June 18, 2021, the options will expire on September 16, 2021.

SEC source: 0001127602-21-015817 · form4.xml · nonDerivative · entry 4

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,474

F1 · shares: These shares were withheld or surrendered to pay the insider's option exercise price and tax withholding obligations incurred in connection with the exercise of the stock options being reported herein.

SEC source: 0001127602-21-015817 · form4.xml · nonDerivative · entry 3

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-015817 · form4.xml · nonDerivative · entry 2

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,239

F1 · shares: These shares were withheld or surrendered to pay the insider's option exercise price and tax withholding obligations incurred in connection with the exercise of the stock options being reported herein.

SEC source: 0001127602-21-015817 · form4.xml · nonDerivative · entry 1

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-015512 · form4.xml · nonDerivative · entry 1

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,429

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-21-013960 · form4.xml · nonDerivative · entry 2

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,168

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-21-013958 · form4.xml · nonDerivative · entry 2

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,259

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-21-013950 · form4.xml · nonDerivative · entry 2

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,521

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 15, 2021, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-21-013961 · form4.xml · nonDerivative · entry 1

Williams Terrance · CIK 0001798480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,108

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013960 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,118

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013959 · form4.xml · nonDerivative · entry 1

SCHLICHTING NANCY M · CIK 0001376358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,201

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013958 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,252

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013957 · form4.xml · nonDerivative · entry 1

Maryland Patricia Anne · CIK 0001798468 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,108

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013956 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,392

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013955 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,419

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013954 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,392

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013953 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,009

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013952 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,486

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013951 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,249

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013950 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,354

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-21-013949 · form4.xml · nonDerivative · entry 1

CARMICHAEL GREG D · CIK 0001247734 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,108

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-22-001395 · form5.xml · nonDerivative · entry 1

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,269

F1 · kind: Represents shares of Common Stock that the reporting person donated as a gift to Abilene Christian University

SEC source: 0001127602-21-009843 · form4.xml · nonDerivative · entry 1

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,642

F1 · price: This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $81.40 to $81.48, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

SEC source: 0001127602-21-009368 · form4.xml · derivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,410

Underlying: Encompass Health Common Stock · 53,410 shares

Expires 2031-03-02

F1 · shares: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2022.

SEC source: 0001127602-21-009367 · form4.xml · derivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,620

Underlying: Encompass Health Common Stock · 16,620 shares

Expires 2031-03-02

F1 · shares: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2022.

SEC source: 0001127602-21-009366 · form4.xml · derivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,375

Underlying: Encompass Health Common Stock · 9,375 shares

Expires 2031-03-02

F1 · shares: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2022.

SEC source: 0001127602-21-009365 · form4.xml · derivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,887

Underlying: Encompass Health Common Stock · 19,887 shares

Expires 2031-03-02

F1 · shares: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2022.

SEC source: 0001127602-21-009364 · form4.xml · derivative · entry 1

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,375

Underlying: Encompass Health Common Stock · 9,375 shares

Expires 2031-03-02

F1 · shares: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 2, 2022.

SEC source: 0001127602-21-007895 · form4.xml · nonDerivative · entry 3

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 397,551

F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-007895 · form4.xml · nonDerivative · entry 2

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 384,882

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019

SEC source: 0001127602-21-007894 · form4.xml · nonDerivative · entry 3

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,231

F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-21-007894 · form4.xml · nonDerivative · entry 2

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,425

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 21, 2019

SEC source: 0001127602-21-007892 · form4.xml · nonDerivative · entry 3

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,854

F3 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.